nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ALB—melanoma	0.222	0.512	CbGaD
Liotrix—ABCB1—melanoma	0.211	0.488	CbGaD
Liotrix—SLCO1B3—Docetaxel—melanoma	0.102	0.413	CbGbCtD
Liotrix—ALB—Vemurafenib—melanoma	0.0944	0.384	CbGbCtD
Liotrix—ABCB1—Dactinomycin—melanoma	0.0328	0.134	CbGbCtD
Liotrix—ABCB1—Docetaxel—melanoma	0.017	0.0689	CbGbCtD
Liotrix—SLC22A8—optic choroid—melanoma	0.00478	0.106	CbGeAlD
Liotrix—SERPINA7—neck—melanoma	0.0046	0.102	CbGeAlD
Liotrix—Infertility—Carmustine—melanoma	0.00438	0.0314	CcSEcCtD
Liotrix—Infertility—Temozolomide—melanoma	0.00423	0.0304	CcSEcCtD
Liotrix—Bronchopneumonia—Docetaxel—melanoma	0.00336	0.0241	CcSEcCtD
Liotrix—Clotting—Temozolomide—melanoma	0.00309	0.0222	CcSEcCtD
Liotrix—THRB—neck—melanoma	0.00284	0.0628	CbGeAlD
Liotrix—THRA—neck—melanoma	0.00284	0.0628	CbGeAlD
Liotrix—SLC16A2—neck—melanoma	0.00257	0.0569	CbGeAlD
Liotrix—TTR—neck—melanoma	0.00211	0.0467	CbGeAlD
Liotrix—SLCO4C1—mammalian vulva—melanoma	0.00175	0.0386	CbGeAlD
Liotrix—SLC16A10—neck—melanoma	0.00166	0.0367	CbGeAlD
Liotrix—TTR—eye—melanoma	0.00157	0.0347	CbGeAlD
Liotrix—Coagulopathy—Dactinomycin—melanoma	0.00157	0.0113	CcSEcCtD
Liotrix—TTR—retina—melanoma	0.00156	0.0344	CbGeAlD
Liotrix—Necrosis—Dactinomycin—melanoma	0.00155	0.0112	CcSEcCtD
Liotrix—Extravasation—Bleomycin—melanoma	0.0015	0.0108	CcSEcCtD
Liotrix—Tenderness—Bleomycin—melanoma	0.0015	0.0108	CcSEcCtD
Liotrix—Necrosis—Carmustine—melanoma	0.00146	0.0105	CcSEcCtD
Liotrix—Abscess—Carmustine—melanoma	0.00144	0.0104	CcSEcCtD
Liotrix—Coagulopathy—Temozolomide—melanoma	0.00142	0.0102	CcSEcCtD
Liotrix—Extravasation—Dactinomycin—melanoma	0.0014	0.01	CcSEcCtD
Liotrix—SLCO4A1—retina—melanoma	0.00139	0.0308	CbGeAlD
Liotrix—Ulcer—Bleomycin—melanoma	0.00138	0.00993	CcSEcCtD
Liotrix—Hypocalcaemia—Dactinomycin—melanoma	0.00133	0.00957	CcSEcCtD
Liotrix—Menstruation irregular—Docetaxel—melanoma	0.00133	0.00952	CcSEcCtD
Liotrix—Extravasation—Carmustine—melanoma	0.00131	0.0094	CcSEcCtD
Liotrix—Ulcer—Dactinomycin—melanoma	0.00129	0.00927	CcSEcCtD
Liotrix—Wheezing—Bleomycin—melanoma	0.00127	0.00913	CcSEcCtD
Liotrix—Weight decreased—Vemurafenib—melanoma	0.00123	0.0088	CcSEcCtD
Liotrix—THRB—head—melanoma	0.0012	0.0265	CbGeAlD
Liotrix—THRA—head—melanoma	0.0012	0.0265	CbGeAlD
Liotrix—SLCO4A1—mammalian vulva—melanoma	0.00112	0.0247	CbGeAlD
Liotrix—Phlebitis—Bleomycin—melanoma	0.0011	0.00792	CcSEcCtD
Liotrix—SLC16A2—head—melanoma	0.00109	0.024	CbGeAlD
Liotrix—Intestinal obstruction—Docetaxel—melanoma	0.00108	0.00773	CcSEcCtD
Liotrix—Disorientation—Bleomycin—melanoma	0.00106	0.00763	CcSEcCtD
Liotrix—SLC10A1—head—melanoma	0.00106	0.0234	CbGeAlD
Liotrix—Sepsis—Dactinomycin—melanoma	0.00106	0.00761	CcSEcCtD
Liotrix—Coma—Carmustine—melanoma	0.00104	0.0075	CcSEcCtD
Liotrix—Phlebitis—Dactinomycin—melanoma	0.00103	0.00738	CcSEcCtD
Liotrix—SLCO1C1—head—melanoma	0.000997	0.022	CbGeAlD
Liotrix—Sepsis—Carmustine—melanoma	0.000991	0.00712	CcSEcCtD
Liotrix—SLC16A10—mammalian vulva—melanoma	0.000979	0.0216	CbGeAlD
Liotrix—Cerebrovascular accident—Bleomycin—melanoma	0.000969	0.00696	CcSEcCtD
Liotrix—SLC22A8—eye—melanoma	0.000962	0.0213	CbGeAlD
Liotrix—Phlebitis—Carmustine—melanoma	0.000962	0.00691	CcSEcCtD
Liotrix—Alopecia—Vemurafenib—melanoma	0.000958	0.00688	CcSEcCtD
Liotrix—Swelling—Carmustine—melanoma	0.00094	0.00675	CcSEcCtD
Liotrix—Necrosis—Docetaxel—melanoma	0.000935	0.00672	CcSEcCtD
Liotrix—Dysgeusia—Vemurafenib—melanoma	0.000925	0.00664	CcSEcCtD
Liotrix—TTR—head—melanoma	0.000891	0.0197	CbGeAlD
Liotrix—Extravasation—Docetaxel—melanoma	0.000841	0.00604	CcSEcCtD
Liotrix—THRA—lymph node—melanoma	0.00084	0.0186	CbGeAlD
Liotrix—THRB—lymph node—melanoma	0.00084	0.0186	CbGeAlD
Liotrix—Bronchospasm—Bleomycin—melanoma	0.000808	0.0058	CcSEcCtD
Liotrix—Arthralgia—Vemurafenib—melanoma	0.000804	0.00577	CcSEcCtD
Liotrix—SLCO4A1—head—melanoma	0.000799	0.0177	CbGeAlD
Liotrix—Oliguria—Docetaxel—melanoma	0.000797	0.00572	CcSEcCtD
Liotrix—Affect lability—Temozolomide—melanoma	0.000789	0.00566	CcSEcCtD
Liotrix—Anaphylactic shock—Vemurafenib—melanoma	0.000771	0.00553	CcSEcCtD
Liotrix—Dysphagia—Dactinomycin—melanoma	0.000766	0.0055	CcSEcCtD
Liotrix—Infection—Vemurafenib—melanoma	0.000766	0.0055	CcSEcCtD
Liotrix—SLC16A2—lymph node—melanoma	0.000761	0.0168	CbGeAlD
Liotrix—Mood swings—Temozolomide—melanoma	0.000759	0.00545	CcSEcCtD
Liotrix—Hypokalaemia—Carmustine—melanoma	0.000755	0.00542	CcSEcCtD
Liotrix—Dehydration—Temozolomide—melanoma	0.000745	0.00535	CcSEcCtD
Liotrix—Weight decreased—Bleomycin—melanoma	0.000743	0.00533	CcSEcCtD
Liotrix—Muscular weakness—Carmustine—melanoma	0.000731	0.00525	CcSEcCtD
Liotrix—Hypokalaemia—Temozolomide—melanoma	0.000729	0.00524	CcSEcCtD
Liotrix—Acute coronary syndrome—Bleomycin—melanoma	0.000722	0.00518	CcSEcCtD
Liotrix—Hypotension—Vemurafenib—melanoma	0.00072	0.00517	CcSEcCtD
Liotrix—Myocardial infarction—Bleomycin—melanoma	0.000718	0.00515	CcSEcCtD
Liotrix—Dysphagia—Carmustine—melanoma	0.000717	0.00515	CcSEcCtD
Liotrix—Muscular weakness—Temozolomide—melanoma	0.000707	0.00507	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000702	0.00504	CcSEcCtD
Liotrix—SLCO1C1—lymph node—melanoma	0.000698	0.0154	CbGeAlD
Liotrix—Abdominal distension—Temozolomide—melanoma	0.000697	0.00501	CcSEcCtD
Liotrix—Fluid retention—Docetaxel—melanoma	0.000697	0.005	CcSEcCtD
Liotrix—Dysphagia—Temozolomide—melanoma	0.000693	0.00497	CcSEcCtD
Liotrix—Sweating increased—Temozolomide—melanoma	0.000675	0.00484	CcSEcCtD
Liotrix—Decreased appetite—Vemurafenib—melanoma	0.00067	0.00481	CcSEcCtD
Liotrix—Bronchitis—Temozolomide—melanoma	0.000666	0.00478	CcSEcCtD
Liotrix—Fatigue—Vemurafenib—melanoma	0.000664	0.00477	CcSEcCtD
Liotrix—Constipation—Vemurafenib—melanoma	0.000659	0.00473	CcSEcCtD
Liotrix—Lightheadedness—Docetaxel—melanoma	0.000657	0.00472	CcSEcCtD
Liotrix—Hypoaesthesia—Bleomycin—melanoma	0.000654	0.0047	CcSEcCtD
Liotrix—Sepsis—Docetaxel—melanoma	0.000637	0.00457	CcSEcCtD
Liotrix—ABCB1—blood vessel—melanoma	0.000635	0.014	CbGeAlD
Liotrix—Renal failure—Carmustine—melanoma	0.000628	0.00451	CcSEcCtD
Liotrix—Weight decreased—Temozolomide—melanoma	0.000627	0.0045	CcSEcCtD
Liotrix—Phlebitis—Docetaxel—melanoma	0.000619	0.00444	CcSEcCtD
Liotrix—Flushing—Bleomycin—melanoma	0.00061	0.00438	CcSEcCtD
Liotrix—Body temperature increased—Vemurafenib—melanoma	0.000609	0.00437	CcSEcCtD
Liotrix—Swelling—Docetaxel—melanoma	0.000604	0.00434	CcSEcCtD
Liotrix—Levothyroxine—ALB—melanoma	0.000601	0.299	CrCbGaD
Liotrix—Cardiac failure congestive—Docetaxel—melanoma	0.000588	0.00422	CcSEcCtD
Liotrix—Alopecia—Bleomycin—melanoma	0.000581	0.00417	CcSEcCtD
Liotrix—Levothyroxine—ABCB1—melanoma	0.000573	0.285	CrCbGaD
Liotrix—SLCO1A2—head—melanoma	0.000572	0.0126	CbGeAlD
Liotrix—Hypoaesthesia—Carmustine—melanoma	0.000571	0.0041	CcSEcCtD
Liotrix—Flushing—Dactinomycin—melanoma	0.000569	0.00408	CcSEcCtD
Liotrix—Hypersensitivity—Vemurafenib—melanoma	0.000568	0.00408	CcSEcCtD
Liotrix—Renal impairment—Docetaxel—melanoma	0.00056	0.00402	CcSEcCtD
Liotrix—SLCO4A1—lymph node—melanoma	0.00056	0.0124	CbGeAlD
Liotrix—Asthenia—Vemurafenib—melanoma	0.000553	0.00397	CcSEcCtD
Liotrix—Hypoaesthesia—Temozolomide—melanoma	0.000552	0.00396	CcSEcCtD
Liotrix—SLC22A8—head—melanoma	0.000546	0.0121	CbGeAlD
Liotrix—Cardiac failure—Docetaxel—melanoma	0.000546	0.00392	CcSEcCtD
Liotrix—Pruritus—Vemurafenib—melanoma	0.000545	0.00392	CcSEcCtD
Liotrix—Alopecia—Dactinomycin—melanoma	0.000542	0.00389	CcSEcCtD
Liotrix—Flushing—Carmustine—melanoma	0.000532	0.00382	CcSEcCtD
Liotrix—Diarrhoea—Vemurafenib—melanoma	0.000527	0.00379	CcSEcCtD
Liotrix—Flushing—Temozolomide—melanoma	0.000514	0.00369	CcSEcCtD
Liotrix—Arrhythmia—Carmustine—melanoma	0.000512	0.00368	CcSEcCtD
Liotrix—Dizziness—Vemurafenib—melanoma	0.00051	0.00366	CcSEcCtD
Liotrix—Alopecia—Carmustine—melanoma	0.000507	0.00364	CcSEcCtD
Liotrix—Dehydration—Docetaxel—melanoma	0.000496	0.00356	CcSEcCtD
Liotrix—SLC16A10—lymph node—melanoma	0.000491	0.0108	CbGeAlD
Liotrix—Vomiting—Vemurafenib—melanoma	0.00049	0.00352	CcSEcCtD
Liotrix—Alopecia—Temozolomide—melanoma	0.00049	0.00352	CcSEcCtD
Liotrix—Chest pain—Bleomycin—melanoma	0.000487	0.0035	CcSEcCtD
Liotrix—Rash—Vemurafenib—melanoma	0.000486	0.00349	CcSEcCtD
Liotrix—Dermatitis—Vemurafenib—melanoma	0.000485	0.00349	CcSEcCtD
Liotrix—Headache—Vemurafenib—melanoma	0.000483	0.00347	CcSEcCtD
Liotrix—Dysgeusia—Temozolomide—melanoma	0.000473	0.00339	CcSEcCtD
Liotrix—Confusional state—Bleomycin—melanoma	0.000471	0.00338	CcSEcCtD
Liotrix—Vision blurred—Carmustine—melanoma	0.000471	0.00338	CcSEcCtD
Liotrix—Tremor—Carmustine—melanoma	0.000468	0.00336	CcSEcCtD
Liotrix—Anaphylactic shock—Bleomycin—melanoma	0.000467	0.00335	CcSEcCtD
Liotrix—Oedema—Bleomycin—melanoma	0.000467	0.00335	CcSEcCtD
Liotrix—Infection—Bleomycin—melanoma	0.000464	0.00333	CcSEcCtD
Liotrix—Dysphagia—Docetaxel—melanoma	0.000461	0.00331	CcSEcCtD
Liotrix—Agitation—Carmustine—melanoma	0.000459	0.0033	CcSEcCtD
Liotrix—Nausea—Vemurafenib—melanoma	0.000458	0.00329	CcSEcCtD
Liotrix—Vision blurred—Temozolomide—melanoma	0.000455	0.00327	CcSEcCtD
Liotrix—Bronchospasm—Docetaxel—melanoma	0.000453	0.00325	CcSEcCtD
Liotrix—Tremor—Temozolomide—melanoma	0.000452	0.00325	CcSEcCtD
Liotrix—Angina pectoris—Docetaxel—melanoma	0.000449	0.00322	CcSEcCtD
Liotrix—Anorexia—Bleomycin—melanoma	0.000445	0.0032	CcSEcCtD
Liotrix—Agitation—Temozolomide—melanoma	0.000443	0.00318	CcSEcCtD
Liotrix—Angioedema—Temozolomide—melanoma	0.000441	0.00317	CcSEcCtD
Liotrix—Hypotension—Bleomycin—melanoma	0.000436	0.00313	CcSEcCtD
Liotrix—Oedema—Dactinomycin—melanoma	0.000435	0.00313	CcSEcCtD
Liotrix—Convulsion—Carmustine—melanoma	0.000433	0.00311	CcSEcCtD
Liotrix—Infection—Dactinomycin—melanoma	0.000433	0.00311	CcSEcCtD
Liotrix—Hypertension—Carmustine—melanoma	0.000431	0.0031	CcSEcCtD
Liotrix—Liothyronine—ALB—melanoma	0.000428	0.213	CrCbGaD
Liotrix—Palpitations—Temozolomide—melanoma	0.000426	0.00306	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Bleomycin—melanoma	0.000425	0.00305	CcSEcCtD
Liotrix—Chest pain—Carmustine—melanoma	0.000425	0.00305	CcSEcCtD
Liotrix—Anxiety—Carmustine—melanoma	0.000424	0.00304	CcSEcCtD
Liotrix—Paraesthesia—Bleomycin—melanoma	0.000419	0.00301	CcSEcCtD
Liotrix—Convulsion—Temozolomide—melanoma	0.000418	0.003	CcSEcCtD
Liotrix—Weight decreased—Docetaxel—melanoma	0.000417	0.00299	CcSEcCtD
Liotrix—Hypertension—Temozolomide—melanoma	0.000417	0.00299	CcSEcCtD
Liotrix—Dyspnoea—Bleomycin—melanoma	0.000416	0.00299	CcSEcCtD
Liotrix—Anorexia—Dactinomycin—melanoma	0.000415	0.00298	CcSEcCtD
Liotrix—Confusional state—Carmustine—melanoma	0.000411	0.00295	CcSEcCtD
Liotrix—Arthralgia—Temozolomide—melanoma	0.000411	0.00295	CcSEcCtD
Liotrix—Anxiety—Temozolomide—melanoma	0.000409	0.00294	CcSEcCtD
Liotrix—Liothyronine—ABCB1—melanoma	0.000409	0.203	CrCbGaD
Liotrix—Oedema—Carmustine—melanoma	0.000408	0.00293	CcSEcCtD
Liotrix—Decreased appetite—Bleomycin—melanoma	0.000406	0.00291	CcSEcCtD
Liotrix—Infection—Carmustine—melanoma	0.000405	0.00291	CcSEcCtD
Liotrix—Acute coronary syndrome—Docetaxel—melanoma	0.000405	0.00291	CcSEcCtD
Liotrix—Renal failure—Docetaxel—melanoma	0.000404	0.0029	CcSEcCtD
Liotrix—Myocardial infarction—Docetaxel—melanoma	0.000403	0.00289	CcSEcCtD
Liotrix—ALB—lymph node—melanoma	0.000398	0.00881	CbGeAlD
Liotrix—Tachycardia—Carmustine—melanoma	0.000398	0.00286	CcSEcCtD
Liotrix—Confusional state—Temozolomide—melanoma	0.000397	0.00285	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000397	0.00285	CcSEcCtD
Liotrix—Anaphylactic shock—Temozolomide—melanoma	0.000394	0.00283	CcSEcCtD
Liotrix—Oedema—Temozolomide—melanoma	0.000394	0.00283	CcSEcCtD
Liotrix—Infection—Temozolomide—melanoma	0.000391	0.00281	CcSEcCtD
Liotrix—Anorexia—Carmustine—melanoma	0.000388	0.00279	CcSEcCtD
Liotrix—Feeling abnormal—Bleomycin—melanoma	0.000385	0.00276	CcSEcCtD
Liotrix—Hypotension—Carmustine—melanoma	0.000381	0.00273	CcSEcCtD
Liotrix—Hyperhidrosis—Temozolomide—melanoma	0.000381	0.00273	CcSEcCtD
Liotrix—Decreased appetite—Dactinomycin—melanoma	0.000378	0.00272	CcSEcCtD
Liotrix—Fatigue—Dactinomycin—melanoma	0.000375	0.0027	CcSEcCtD
Liotrix—Anorexia—Temozolomide—melanoma	0.000375	0.0027	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Carmustine—melanoma	0.000371	0.00267	CcSEcCtD
Liotrix—Urticaria—Bleomycin—melanoma	0.000371	0.00266	CcSEcCtD
Liotrix—Body temperature increased—Bleomycin—melanoma	0.000369	0.00265	CcSEcCtD
Liotrix—Insomnia—Carmustine—melanoma	0.000369	0.00265	CcSEcCtD
Liotrix—Hypoaesthesia—Docetaxel—melanoma	0.000367	0.00263	CcSEcCtD
Liotrix—Paraesthesia—Carmustine—melanoma	0.000366	0.00263	CcSEcCtD
Liotrix—Dyspnoea—Carmustine—melanoma	0.000363	0.00261	CcSEcCtD
Liotrix—Feeling abnormal—Dactinomycin—melanoma	0.000359	0.00258	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Temozolomide—melanoma	0.000359	0.00258	CcSEcCtD
Liotrix—Insomnia—Temozolomide—melanoma	0.000356	0.00256	CcSEcCtD
Liotrix—Gastrointestinal pain—Dactinomycin—melanoma	0.000356	0.00256	CcSEcCtD
Liotrix—Decreased appetite—Carmustine—melanoma	0.000354	0.00254	CcSEcCtD
Liotrix—Paraesthesia—Temozolomide—melanoma	0.000354	0.00254	CcSEcCtD
Liotrix—Dyspnoea—Temozolomide—melanoma	0.000351	0.00252	CcSEcCtD
Liotrix—Constipation—Carmustine—melanoma	0.000348	0.0025	CcSEcCtD
Liotrix—Abdominal pain—Dactinomycin—melanoma	0.000344	0.00247	CcSEcCtD
Liotrix—Body temperature increased—Dactinomycin—melanoma	0.000344	0.00247	CcSEcCtD
Liotrix—Hypersensitivity—Bleomycin—melanoma	0.000344	0.00247	CcSEcCtD
Liotrix—Decreased appetite—Temozolomide—melanoma	0.000342	0.00246	CcSEcCtD
Liotrix—Flushing—Docetaxel—melanoma	0.000342	0.00246	CcSEcCtD
Liotrix—Fatigue—Temozolomide—melanoma	0.00034	0.00244	CcSEcCtD
Liotrix—Constipation—Temozolomide—melanoma	0.000337	0.00242	CcSEcCtD
Liotrix—Feeling abnormal—Carmustine—melanoma	0.000336	0.00241	CcSEcCtD
Liotrix—Asthenia—Bleomycin—melanoma	0.000335	0.00241	CcSEcCtD
Liotrix—ABCB1—retina—melanoma	0.000335	0.0074	CbGeAlD
Liotrix—Gastrointestinal pain—Carmustine—melanoma	0.000333	0.00239	CcSEcCtD
Liotrix—Pruritus—Bleomycin—melanoma	0.00033	0.00237	CcSEcCtD
Liotrix—Arrhythmia—Docetaxel—melanoma	0.000329	0.00236	CcSEcCtD
Liotrix—Alopecia—Docetaxel—melanoma	0.000326	0.00234	CcSEcCtD
Liotrix—Feeling abnormal—Temozolomide—melanoma	0.000325	0.00233	CcSEcCtD
Liotrix—Body temperature increased—Carmustine—melanoma	0.000322	0.00231	CcSEcCtD
Liotrix—Abdominal pain—Carmustine—melanoma	0.000322	0.00231	CcSEcCtD
Liotrix—Gastrointestinal pain—Temozolomide—melanoma	0.000322	0.00231	CcSEcCtD
Liotrix—Hypersensitivity—Dactinomycin—melanoma	0.000321	0.0023	CcSEcCtD
Liotrix—Dysgeusia—Docetaxel—melanoma	0.000314	0.00226	CcSEcCtD
Liotrix—Urticaria—Temozolomide—melanoma	0.000313	0.00225	CcSEcCtD
Liotrix—Asthenia—Dactinomycin—melanoma	0.000312	0.00224	CcSEcCtD
Liotrix—Abdominal pain—Temozolomide—melanoma	0.000311	0.00224	CcSEcCtD
Liotrix—Body temperature increased—Temozolomide—melanoma	0.000311	0.00224	CcSEcCtD
Liotrix—Hypersensitivity—Carmustine—melanoma	0.0003	0.00216	CcSEcCtD
Liotrix—Diarrhoea—Dactinomycin—melanoma	0.000298	0.00214	CcSEcCtD
Liotrix—Vomiting—Bleomycin—melanoma	0.000297	0.00213	CcSEcCtD
Liotrix—Rash—Bleomycin—melanoma	0.000294	0.00211	CcSEcCtD
Liotrix—Dermatitis—Bleomycin—melanoma	0.000294	0.00211	CcSEcCtD
Liotrix—Asthenia—Carmustine—melanoma	0.000292	0.0021	CcSEcCtD
Liotrix—Hypersensitivity—Temozolomide—melanoma	0.00029	0.00208	CcSEcCtD
Liotrix—Syncope—Docetaxel—melanoma	0.000288	0.00207	CcSEcCtD
Liotrix—Palpitations—Docetaxel—melanoma	0.000284	0.00204	CcSEcCtD
Liotrix—Asthenia—Temozolomide—melanoma	0.000283	0.00203	CcSEcCtD
Liotrix—Loss of consciousness—Docetaxel—melanoma	0.000282	0.00203	CcSEcCtD
Liotrix—Diarrhoea—Carmustine—melanoma	0.000279	0.002	CcSEcCtD
Liotrix—Pruritus—Temozolomide—melanoma	0.000279	0.002	CcSEcCtD
Liotrix—Convulsion—Docetaxel—melanoma	0.000278	0.002	CcSEcCtD
Liotrix—Nausea—Bleomycin—melanoma	0.000277	0.00199	CcSEcCtD
Liotrix—Hypertension—Docetaxel—melanoma	0.000277	0.00199	CcSEcCtD
Liotrix—Vomiting—Dactinomycin—melanoma	0.000277	0.00199	CcSEcCtD
Liotrix—Rash—Dactinomycin—melanoma	0.000275	0.00197	CcSEcCtD
Liotrix—Chest pain—Docetaxel—melanoma	0.000273	0.00196	CcSEcCtD
Liotrix—Arthralgia—Docetaxel—melanoma	0.000273	0.00196	CcSEcCtD
Liotrix—Dizziness—Carmustine—melanoma	0.000269	0.00194	CcSEcCtD
Liotrix—Diarrhoea—Temozolomide—melanoma	0.000269	0.00193	CcSEcCtD
Liotrix—ABCB1—mammalian vulva—melanoma	0.000268	0.00592	CbGeAlD
Liotrix—Confusional state—Docetaxel—melanoma	0.000264	0.0019	CcSEcCtD
Liotrix—Oedema—Docetaxel—melanoma	0.000262	0.00188	CcSEcCtD
Liotrix—Anaphylactic shock—Docetaxel—melanoma	0.000262	0.00188	CcSEcCtD
Liotrix—Dizziness—Temozolomide—melanoma	0.00026	0.00187	CcSEcCtD
Liotrix—Infection—Docetaxel—melanoma	0.00026	0.00187	CcSEcCtD
Liotrix—Vomiting—Carmustine—melanoma	0.000259	0.00186	CcSEcCtD
Liotrix—Nausea—Dactinomycin—melanoma	0.000259	0.00186	CcSEcCtD
Liotrix—Shock—Docetaxel—melanoma	0.000258	0.00185	CcSEcCtD
Liotrix—Rash—Carmustine—melanoma	0.000257	0.00185	CcSEcCtD
Liotrix—Dermatitis—Carmustine—melanoma	0.000257	0.00184	CcSEcCtD
Liotrix—Tachycardia—Docetaxel—melanoma	0.000256	0.00184	CcSEcCtD
Liotrix—Headache—Carmustine—melanoma	0.000255	0.00183	CcSEcCtD
Liotrix—Vomiting—Temozolomide—melanoma	0.00025	0.0018	CcSEcCtD
Liotrix—Anorexia—Docetaxel—melanoma	0.00025	0.00179	CcSEcCtD
Liotrix—Rash—Temozolomide—melanoma	0.000248	0.00178	CcSEcCtD
Liotrix—Dermatitis—Temozolomide—melanoma	0.000248	0.00178	CcSEcCtD
Liotrix—Headache—Temozolomide—melanoma	0.000247	0.00177	CcSEcCtD
Liotrix—Hypotension—Docetaxel—melanoma	0.000245	0.00176	CcSEcCtD
Liotrix—Nausea—Carmustine—melanoma	0.000242	0.00174	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Docetaxel—melanoma	0.000239	0.00171	CcSEcCtD
Liotrix—Insomnia—Docetaxel—melanoma	0.000237	0.0017	CcSEcCtD
Liotrix—Paraesthesia—Docetaxel—melanoma	0.000235	0.00169	CcSEcCtD
Liotrix—Nausea—Temozolomide—melanoma	0.000234	0.00168	CcSEcCtD
Liotrix—Dyspnoea—Docetaxel—melanoma	0.000233	0.00168	CcSEcCtD
Liotrix—Decreased appetite—Docetaxel—melanoma	0.000228	0.00163	CcSEcCtD
Liotrix—Fatigue—Docetaxel—melanoma	0.000226	0.00162	CcSEcCtD
Liotrix—Constipation—Docetaxel—melanoma	0.000224	0.00161	CcSEcCtD
Liotrix—Feeling abnormal—Docetaxel—melanoma	0.000216	0.00155	CcSEcCtD
Liotrix—Gastrointestinal pain—Docetaxel—melanoma	0.000214	0.00154	CcSEcCtD
Liotrix—Abdominal pain—Docetaxel—melanoma	0.000207	0.00149	CcSEcCtD
Liotrix—Body temperature increased—Docetaxel—melanoma	0.000207	0.00149	CcSEcCtD
Liotrix—Hypersensitivity—Docetaxel—melanoma	0.000193	0.00139	CcSEcCtD
Liotrix—ABCB1—head—melanoma	0.000192	0.00424	CbGeAlD
Liotrix—Asthenia—Docetaxel—melanoma	0.000188	0.00135	CcSEcCtD
Liotrix—Pruritus—Docetaxel—melanoma	0.000185	0.00133	CcSEcCtD
Liotrix—Diarrhoea—Docetaxel—melanoma	0.000179	0.00129	CcSEcCtD
Liotrix—Dizziness—Docetaxel—melanoma	0.000173	0.00124	CcSEcCtD
Liotrix—Vomiting—Docetaxel—melanoma	0.000167	0.0012	CcSEcCtD
Liotrix—Rash—Docetaxel—melanoma	0.000165	0.00119	CcSEcCtD
Liotrix—Dermatitis—Docetaxel—melanoma	0.000165	0.00118	CcSEcCtD
Liotrix—Headache—Docetaxel—melanoma	0.000164	0.00118	CcSEcCtD
Liotrix—Nausea—Docetaxel—melanoma	0.000156	0.00112	CcSEcCtD
Liotrix—ABCB1—lymph node—melanoma	0.000134	0.00297	CbGeAlD
Liotrix—SLCO1A2—Metabolism—CYP1B1—melanoma	2.06e-05	0.000153	CbGpPWpGaD
Liotrix—TTR—Disease—CTNNB1—melanoma	2.04e-05	0.000151	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.04e-05	0.000151	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.03e-05	0.000151	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HPSE—melanoma	2.03e-05	0.000151	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTAP—melanoma	2.02e-05	0.00015	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.02e-05	0.00015	CbGpPWpGaD
Liotrix—ALB—Metabolism—HPSE—melanoma	2.02e-05	0.00015	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	2.01e-05	0.000149	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CUBN—melanoma	1.99e-05	0.000148	CbGpPWpGaD
Liotrix—TTR—Disease—CDKN1A—melanoma	1.99e-05	0.000148	CbGpPWpGaD
Liotrix—TTR—Disease—PTEN—melanoma	1.99e-05	0.000148	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PRKCA—melanoma	1.99e-05	0.000148	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HGF—melanoma	1.98e-05	0.000147	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.98e-05	0.000147	CbGpPWpGaD
Liotrix—ALB—Metabolism—CUBN—melanoma	1.98e-05	0.000147	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GNA11—melanoma	1.97e-05	0.000147	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—BRAF—melanoma	1.97e-05	0.000147	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ERCC2—melanoma	1.97e-05	0.000146	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CSF2—melanoma	1.96e-05	0.000146	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—ALB—melanoma	1.94e-05	0.000144	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—FASN—melanoma	1.93e-05	0.000144	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.93e-05	0.000143	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SDHD—melanoma	1.93e-05	0.000143	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—BSG—melanoma	1.93e-05	0.000143	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CSPG4—melanoma	1.93e-05	0.000143	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IGF1—melanoma	1.92e-05	0.000143	CbGpPWpGaD
Liotrix—ALB—Metabolism—SDHD—melanoma	1.91e-05	0.000142	CbGpPWpGaD
Liotrix—ALB—Metabolism—CSPG4—melanoma	1.91e-05	0.000142	CbGpPWpGaD
Liotrix—ALB—Metabolism—BSG—melanoma	1.91e-05	0.000142	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.91e-05	0.000142	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CB—melanoma	1.9e-05	0.000141	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—SLC5A5—melanoma	1.9e-05	0.000141	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTGS2—melanoma	1.89e-05	0.00014	CbGpPWpGaD
Liotrix—ALB—Hemostasis—ITGB3—melanoma	1.88e-05	0.00014	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PRKCA—melanoma	1.88e-05	0.00014	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.87e-05	0.000139	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GPAM—melanoma	1.86e-05	0.000139	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.86e-05	0.000138	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAP2K1—melanoma	1.86e-05	0.000138	CbGpPWpGaD
Liotrix—ALB—Metabolism—GPAM—melanoma	1.85e-05	0.000138	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.85e-05	0.000138	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CD—melanoma	1.85e-05	0.000137	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CD44—melanoma	1.84e-05	0.000136	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GNAQ—melanoma	1.84e-05	0.000136	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.82e-05	0.000135	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PHGDH—melanoma	1.8e-05	0.000134	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—LUM—melanoma	1.8e-05	0.000134	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.8e-05	0.000134	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.78e-05	0.000132	CbGpPWpGaD
Liotrix—TTR—Disease—STAT3—melanoma	1.78e-05	0.000132	CbGpPWpGaD
Liotrix—TTR—Disease—NRAS—melanoma	1.77e-05	0.000132	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HPSE—melanoma	1.77e-05	0.000131	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	1.77e-05	0.000131	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—FGF2—melanoma	1.77e-05	0.000131	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP1B1—melanoma	1.76e-05	0.000131	CbGpPWpGaD
Liotrix—ALB—Hemostasis—RAC1—melanoma	1.74e-05	0.000129	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CUBN—melanoma	1.74e-05	0.000129	CbGpPWpGaD
Liotrix—THRA—Gene Expression—AKT1—melanoma	1.73e-05	0.000129	CbGpPWpGaD
Liotrix—THRB—Gene Expression—AKT1—melanoma	1.73e-05	0.000129	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.71e-05	0.000127	CbGpPWpGaD
Liotrix—TTR—Disease—MAPK3—melanoma	1.7e-05	0.000126	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ABCB1—melanoma	1.69e-05	0.000126	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MMP1—melanoma	1.69e-05	0.000125	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.68e-05	0.000125	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—BSG—melanoma	1.68e-05	0.000125	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SDHD—melanoma	1.68e-05	0.000125	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CSPG4—melanoma	1.68e-05	0.000125	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CDK2—melanoma	1.65e-05	0.000123	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MDM2—melanoma	1.65e-05	0.000123	CbGpPWpGaD
Liotrix—TTR—Disease—MYC—melanoma	1.65e-05	0.000123	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTEN—melanoma	1.64e-05	0.000122	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.63e-05	0.000121	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ERBB2—melanoma	1.63e-05	0.000121	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GPAM—melanoma	1.62e-05	0.000121	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.62e-05	0.00012	CbGpPWpGaD
Liotrix—TTR—Disease—MAPK1—melanoma	1.61e-05	0.00012	CbGpPWpGaD
Liotrix—TTR—Disease—EGFR—melanoma	1.61e-05	0.00012	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CB—melanoma	1.61e-05	0.00012	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.59e-05	0.000118	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PLA2G6—melanoma	1.59e-05	0.000118	CbGpPWpGaD
Liotrix—ALB—Metabolism—PLA2G6—melanoma	1.58e-05	0.000117	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PRKCA—melanoma	1.56e-05	0.000116	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CG—melanoma	1.55e-05	0.000116	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.55e-05	0.000115	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.55e-05	0.000115	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ERCC2—melanoma	1.55e-05	0.000115	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL8—melanoma	1.55e-05	0.000115	CbGpPWpGaD
Liotrix—ALB—Hemostasis—FN1—melanoma	1.54e-05	0.000114	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.54e-05	0.000114	CbGpPWpGaD
Liotrix—TTR—Disease—KRAS—melanoma	1.52e-05	0.000113	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS2—melanoma	1.52e-05	0.000113	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.51e-05	0.000112	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.51e-05	0.000112	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1B—melanoma	1.51e-05	0.000112	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PPARG—melanoma	1.5e-05	0.000112	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CASP3—melanoma	1.48e-05	0.00011	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL2—melanoma	1.48e-05	0.00011	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CG—melanoma	1.47e-05	0.000109	CbGpPWpGaD
Liotrix—ALB—Hemostasis—EGF—melanoma	1.46e-05	0.000108	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ABCB1—melanoma	1.45e-05	0.000108	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.44e-05	0.000107	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCND1—melanoma	1.44e-05	0.000107	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.43e-05	0.000106	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CTNNB1—melanoma	1.43e-05	0.000106	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—VCAN—melanoma	1.42e-05	0.000106	CbGpPWpGaD
Liotrix—ALB—Metabolism—VCAN—melanoma	1.42e-05	0.000105	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—melanoma	1.4e-05	0.000104	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—melanoma	1.4e-05	0.000104	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1A—melanoma	1.39e-05	0.000104	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTEN—melanoma	1.39e-05	0.000103	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NFKB1—melanoma	1.38e-05	0.000103	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PLA2G6—melanoma	1.38e-05	0.000103	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CD—melanoma	1.37e-05	0.000102	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ALB—melanoma	1.35e-05	0.0001	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.35e-05	0.0001	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IGF1—melanoma	1.35e-05	0.0001	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.34e-05	9.96e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.33e-05	9.91e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PRKCA—melanoma	1.33e-05	9.91e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ERCC2—melanoma	1.32e-05	9.83e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.31e-05	9.76e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.3e-05	9.67e-05	CbGpPWpGaD
Liotrix—TTR—Disease—HRAS—melanoma	1.3e-05	9.63e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CD—melanoma	1.29e-05	9.62e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.29e-05	9.61e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.28e-05	9.52e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.27e-05	9.44e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—melanoma	1.26e-05	9.33e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STAT3—melanoma	1.24e-05	9.24e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—VCAN—melanoma	1.24e-05	9.22e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NRAS—melanoma	1.24e-05	9.22e-05	CbGpPWpGaD
Liotrix—TTR—Disease—IL6—melanoma	1.24e-05	9.22e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CG—melanoma	1.22e-05	9.08e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP17A1—melanoma	1.2e-05	8.93e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP17A1—melanoma	1.19e-05	8.88e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CB—melanoma	1.19e-05	8.85e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK3—melanoma	1.19e-05	8.83e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.18e-05	8.8e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—melanoma	1.18e-05	8.77e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PPARG—melanoma	1.18e-05	8.76e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.18e-05	8.75e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.17e-05	8.69e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—melanoma	1.16e-05	8.62e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—melanoma	1.16e-05	8.58e-05	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—melanoma	1.14e-05	8.5e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GNA11—melanoma	1.13e-05	8.43e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK1—melanoma	1.13e-05	8.4e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—melanoma	1.13e-05	8.4e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GNA11—melanoma	1.13e-05	8.38e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CB—melanoma	1.13e-05	8.38e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—FASN—melanoma	1.11e-05	8.25e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—FASN—melanoma	1.1e-05	8.2e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.1e-05	8.14e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC5A5—melanoma	1.09e-05	8.12e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.09e-05	8.1e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC5A5—melanoma	1.09e-05	8.07e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CD—melanoma	1.07e-05	7.98e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.07e-05	7.97e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—melanoma	1.07e-05	7.93e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALB—melanoma	1.06e-05	7.88e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GNAQ—melanoma	1.05e-05	7.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CD44—melanoma	1.05e-05	7.84e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GNAQ—melanoma	1.05e-05	7.79e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CD44—melanoma	1.05e-05	7.79e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP17A1—melanoma	1.05e-05	7.78e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CG—melanoma	1.04e-05	7.76e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL2—melanoma	1.04e-05	7.7e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.03e-05	7.67e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTEN—melanoma	1.03e-05	7.65e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.03e-05	7.63e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.02e-05	7.6e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.02e-05	7.56e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP1B1—melanoma	1.01e-05	7.51e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PPARG—melanoma	1.01e-05	7.49e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP1B1—melanoma	1.01e-05	7.47e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GNA11—melanoma	9.88e-06	7.34e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—melanoma	9.81e-06	7.29e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.69e-06	7.2e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—FASN—melanoma	9.67e-06	7.19e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC5A5—melanoma	9.52e-06	7.07e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—melanoma	9.49e-06	7.05e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—melanoma	9.47e-06	7.04e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CB—melanoma	9.36e-06	6.96e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—melanoma	9.28e-06	6.89e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GNAQ—melanoma	9.19e-06	6.83e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CD44—melanoma	9.19e-06	6.83e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CD—melanoma	9.18e-06	6.82e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HRAS—melanoma	9.07e-06	6.74e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALB—melanoma	9.07e-06	6.74e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.93e-06	6.63e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.87e-06	6.59e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP1B1—melanoma	8.81e-06	6.55e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—melanoma	8.8e-06	6.54e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NRAS—melanoma	8.7e-06	6.46e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6—melanoma	8.68e-06	6.45e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MAPK3—melanoma	8.33e-06	6.19e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCB1—melanoma	8.33e-06	6.19e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCB1—melanoma	8.28e-06	6.15e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTEN—melanoma	8.09e-06	6.01e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—melanoma	8.01e-06	5.95e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CB—melanoma	8.01e-06	5.95e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—melanoma	7.93e-06	5.89e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MAPK1—melanoma	7.92e-06	5.89e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PRKCA—melanoma	7.66e-06	5.69e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PRKCA—melanoma	7.62e-06	5.66e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ERCC2—melanoma	7.6e-06	5.65e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ERCC2—melanoma	7.56e-06	5.62e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—melanoma	7.49e-06	5.56e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—melanoma	7.26e-06	5.4e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTEN—melanoma	6.92e-06	5.14e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—melanoma	6.88e-06	5.11e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PRKCA—melanoma	6.68e-06	4.96e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—melanoma	6.65e-06	4.94e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ERCC2—melanoma	6.62e-06	4.92e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HRAS—melanoma	6.36e-06	4.73e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.3e-06	4.68e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.26e-06	4.65e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CG—melanoma	6e-06	4.46e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CG—melanoma	5.97e-06	4.44e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—melanoma	5.93e-06	4.41e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPARG—melanoma	5.79e-06	4.3e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPARG—melanoma	5.76e-06	4.28e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—melanoma	5.71e-06	4.24e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—melanoma	5.62e-06	4.17e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CD—melanoma	5.28e-06	3.92e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CD—melanoma	5.25e-06	3.9e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CG—melanoma	5.23e-06	3.89e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALB—melanoma	5.21e-06	3.87e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPARG—melanoma	5.05e-06	3.75e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—melanoma	4.88e-06	3.63e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—melanoma	4.66e-06	3.46e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CB—melanoma	4.6e-06	3.42e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CD—melanoma	4.6e-06	3.42e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CB—melanoma	4.57e-06	3.4e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—melanoma	4.56e-06	3.39e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALB—melanoma	4.54e-06	3.37e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—melanoma	4.53e-06	3.37e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CB—melanoma	4.01e-06	2.98e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—melanoma	3.99e-06	2.96e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTEN—melanoma	3.97e-06	2.95e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—melanoma	3.97e-06	2.95e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTEN—melanoma	3.95e-06	2.94e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTEN—melanoma	3.46e-06	2.57e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—melanoma	2.8e-06	2.08e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—melanoma	2.79e-06	2.07e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—melanoma	2.44e-06	1.82e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—melanoma	2.29e-06	1.7e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—melanoma	2.28e-06	1.69e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—melanoma	2e-06	1.48e-05	CbGpPWpGaD
